Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2994)
All Articles published online
|
Publishing Process of This Article
|
Mar 16, 2022 (publication date) through Jul 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yan FF, Jiang Q, Ru B, Fei XJ, Ruan J, Zhang XC. Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody: A case report. World J Clin Cases 2022; 10(8): 2497-2503 [PMID: 35434068 DOI: 10.12998/wjcc.v10.i8.2497] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i8/2497.htm |
| Number | Citing Articles |
| 1 |
Mary Kate Kilroy, SoYoung Park, Wasim Feroz, Hima Patel, Rosalin Mishra, Samar Alanazi, Joan T. Garrett. HER3 Alterations in Cancer and Potential Clinical Implications. Cancers 2022; 14(24): 6174 doi: 10.3390/cancers14246174
|